Mei Feng (美丰)美丰
This is a medicine registration record from NMPA data.本页为国家药监局药品注册记录。
Labeled sections from the recorded Chinese source are included below. English wording is a reference translation when one is on file, not an official English label.本记录未接入产品级适应症/安全性标注字段。
生产企业Manufacturer
- 江苏豪森药业股份有限公司Chinese legal name: 江苏豪森药业股份有限公司
主要成分Active Ingredients
- 头孢氨苄cephalexin
药物知识说明
头孢氨苄是一种在国家药监局注册认定的药品。该药品含有头孢氨苄-91cec8b8等成分。
该药品关联的活性成分包括：头孢氨苄cephalexin。这些成分信息来自国家药监局数据库。
该药品标注的生产企业为：江苏豪森药业股份有限公司Chinese legal name: 江苏豪森药业股份有限公司。
您可以探索含有相同成分的其他药品：头孢氨苄-91cec8b8成分药品。
本页面内容来自国家药监局数据库，MedicineGraph在此基础上提供关系图谱和知识导航。
Medicine Knowledge
cephalexin is a medicine registered with the national drug regulatory authority. It contains cephalexin as active ingredient(s).
Active ingredients associated with this product: cephalexincephalexin.
Manufacturers recorded for this product: 江苏豪森药业股份有限公司Chinese legal name: 江苏豪森药业股份有限公司.
Explore other medicines containing the same ingredient: cephalexin products.
Source: MedicineGraph authoritative database. Relationships derived from registered product information.
这是什么What is this
- 通用名/品名Recorded product name: 美丰Recorded Chinese name: 美丰
- 剂型Dosage form: 片剂Tablets
- 规格Specification: 0.25g*20片0.25 g × 20 tablets
本段仅展示注册/说明书已记录的身份属性，不含适应症或用法建议。Identity attributes from registration/leaflet records only; no indications or usage advice.
主要成分Ingredients
生产企业Manufacturer
- 江苏豪森药业股份有限公司Chinese legal name: 江苏豪森药业股份有限公司
注册信息NMPA approval number
- 批准文号NMPA approval number: 国药准字H10960287
相关问题Questions
信息来源Source and scope
国家药品监督管理局（中国）药品注册数据及已接入说明书字段。National Medical Products Administration (China) medicine-registration data and linked leaflet fields.
- 品名来源Name source: 10多万条药品说明书数据库 (HIGH)Package-insert database (more than 100,000 records) (HIGH)
- 生产企业来源Manufacturer source: 10多万条药品说明书数据库Package-insert database (more than 100,000 records)
- 剂型来源Dosage-form source: 10多万条药品说明书数据库Package-insert database (more than 100,000 records)
范围：当前 MedicineGraph 注册记录及已记录的精确关系；非完整目录，亦不构成疗效等同主张，也不支持换用判断。不含适应症/安全性推断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence. No inferred indications/safety.
本段为已核准说明书原文摘录（非改写、非AI摘要），非正式英文标签，亦不构成用药建议。 Not an official English label and not medical advice. English wording, when shown, is a reference translation of the Chinese source label.
English translation for reference. Translated from the Chinese source label. Not an official English label and not medical advice.
NMPA approval number
国药准字H10960287
Manufacturer
Chinese legal name: 江苏豪森药业股份有限公司 (domestically manufactured)
Indications
English translation unavailable. The original Chinese source label remains available below.
Dosage and administration
English translation unavailable. The original Chinese source label remains available below.
Adverse reactions
English translation unavailable. The original Chinese source label remains available below.
Contraindications
English translation unavailable. The original Chinese source label remains available below.
Precautions
English translation unavailable. The original Chinese source label remains available below.
Storage
English translation unavailable. The original Chinese source label remains available below.
Specification
0.25 g × 20 tablets
中文说明书原文Original Chinese source label
批准文号
国药准字H10960287
生产企业
江苏豪森药业股份有限公司(国产)
适应症
本品适用于金黄色葡萄球菌、溶血性链球菌、肺炎球菌、大肠杆菌、肺炎杆菌、流感杆菌、痢疾杆菌等敏感菌株引起的下列部位的轻、中度感染;扁桃体炎、扁桃体周炎、咽喉炎、支气管炎、哮喘和支气管扩张感染以及手术后胸腔感染;急性及慢性肾盂肾炎、膀胱炎、前列腺炎及泌尿生殖系统感染;中耳炎、外耳炎、鼻窦炎;上颌骨周炎、上颌骨骨膜炎、上颌骨髓炎;急性腭炎、牙槽脓肿、根尖性牙周炎、智齿周围炎、拔牙后感染;睑腺炎、睑炎、急性泪囊炎;毛囊炎、疖、丹毒、蜂窝组织炎、脓疱病、痈、痤疮感染、皮下脓肿、创伤感染、乳腺炎、淋巴管炎等。
用法用量
?成年人及体重20公斤以上儿童，常用量每日1~2克（或4~8片），一天剂量分2次口服（每次2~4片）。或遵医嘱。
不良反应
?偶见恶心、呕吐、腹泻、软便、腹痛、食欲不振、胃部不适感等症状。?
禁忌
对头孢菌素类抗生素过敏者禁用。
注意事项
1.对青霉素过敏者慎用。|2.肾功能严重损坏者应酌情减量。
贮藏
遮光，密闭在凉暗外保存。
规格
0.25g*20片
信息来源Source and scope
国家药品监督管理局（中国）药品注册数据。National Medical Products Administration (China) medicine-registration data.
范围：当前 MedicineGraph 注册记录及已记录的精确关系；非完整目录，亦不构成疗效等同主张，也不支持换用判断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence.